4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
METIS TECHBIO-P (7666) operates in the Biotechnology industry and is headquartered in Beijing, China. Its market capitalization is roughly CNY 13 billion. In the fiscal year ended 2025-12-31, 7666 reported CNY 105M in revenue and (CNY 392M) in net income.
Metis TechBio Co., Ltd. engages in research and development of AI-empowered nanomaterial for the delivery and application of active agents across carbon-based life forms in Chinese Mainland and United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | CNY 105M | CNY 2M | CNY 9M | CNY 1M |
| Gross Profit | CNY 103M | CNY 1M | CNY 6M | CNY 0M |
| Operating Income (EBIT) | (CNY 354M) | (CNY 380M) | (CNY 393M) | (CNY 377M) |
| Net Income | (CNY 392M) | (CNY 499M) | (CNY 582M) | (CNY 512M) |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Total Revenue | CNY 3M | CNY 0M |
| Gross Profit | CNY 2M | CNY 0M |
| Operating Income (EBIT) | (CNY 142M) | (CNY 96M) |
| Net Income | (CNY 145M) | (CNY 123M) |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | CNY 1.3B | CNY 1.0B | CNY 1.3B | CNY 617M |
| Total Liabilities | CNY 249M | CNY 2.4B | CNY 2.3B | CNY 707M |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 7666 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms